Using a Novel Skin Tag Removal Device

Running, not enrolling · Not applicable

Conditions studied: Achrochordon

In brief

The aim of this study is to investigate the use of a mechanical device to remove skin tags in adults. The device ("Skin Tag Removal", or STR) utilizes the ligation method by applying a silicone band around the base of a skin tag, therefore restricting the blood supply, which is vital to its growth and survival. Because this method does not include freezing or burning of tissue in or around the skin tag, it could be considered less invasive and less risky than other options.

Key facts

Study ID

NCT06463613

Run by

UK Innovations GP LTD

People needed

200

Starts

2024-06-03

Expected to finish

2026-01-07

Last updated by the study team

2025-11-13

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults at least 22 years of age.
• Must be able to understand, speak, and read English sufficiently for completion of the trial.
• Subject has at least one skin tag meeting ALL of the following requirements:
• no previous attempts to remove the skin tag(s) of investigation, including skin tags that were treated in a previous version of this protocol
• measuring between 4mm and 6mm at the base. Skin tags measuring larger than 6mm can be rounded down based on investigator's discretion.
• not located around the eye, on the eyelid, or in the groin area
• if treating two tags, only one may be located in axilla
• free of any active skin infection \& area to treat tag has no severe eczema
• located in an area where participant can take a self-taken photo
• does not, in the opinion of the Investigator, require an evaluation by pathology at the time of screening
• Subject has access to the internet via smartphone to complete the eDiary

You may not qualify if…

• Significant medical condition or other circumstance which, in the opinion of the Investigator, would preclude compliance with the protocol, adequate cooperation in the trial or providing informed consent, or may prevent the subject from safely participating in the trial
• Any prior history of skin-related cancer
• Subject states that they are currently pregnant or intending to become pregnant during the course of the study
• Has an allergy to latex
• Current diagnosis of a bleeding disorder included but not limited to Hemophilia or Von Willebrand disease
• Currently being treated with blood thinners (use of 81 mg of Aspirin is not exclusionary)
• Currently being treated with topical steroids at site of skin tag of interest or oral steroids
• Currently immunocompromised by conditions such as diabetes (either Types 1 or 2, regardless of level of control) or receiving immunosuppressant therapy
• Current MRSA infection
• Diagnosis or any history of keloid or hypertrophic scarring
• Current or recent participation within the last 30 days in another interventional clinical trial

Where it is running

• Center for Dermatology Clinical Research, Inc. — Fremont, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.